secwatch.observer — SEC 8-K summary
======================================

Issuer:     ArriVent BioPharma, Inc. (AVBP)
CIK:        0001868279
Form:       8-K/A
Filed at:   2024-07-09T23:59:59+00:00
Accession:  0001104659-24-078587
Event type: leadership
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

ArriVent BioPharma appoints Dr. Hohneker to two board committees
----------------------------------------------------------------

- Dr. John Hohneker appointed to Nominating and Corporate Governance Committee, effective July 3, 2024.
- Also appointed to Compensation Committee of the Board, effective same date.
- Amendment corrects omission from original May 16, 2024 8-K reporting his director election.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1868279/000110465924078587/0001104659-24-078587-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1868279/000110465924078587/tm2419108d2_8ka.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-078587

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer